Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|December 18, 2004
Tubulin-polymerization inhibitors derived from thalidomideShunsuke Inatsuki, Tomomi Noguchi, Hiroyuki Miyachi, et al.Therapeutic Innovation & Regulatory Science|January 4, 2021
Effect of Hepatitis C Drugs on Blood Coagulability in Patients on Warfarin Using the Medical Information Database Network (MID-NET<sup>®</sup>) in JapanSono Sawada, Takashi Ando, Mai Hirano, et al.Clinical Pharmacology and Therapeutics|April 18, 2021
Nested Case-Control Study Utilizing MID-NET® on Thrombocytopenia Associated With Pegfilgrastim in Patients Treated With Antineoplastic AgentsKazuhiro Kajiyama, Chieko Ishiguro, Takashi Ando, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 6, 2004
[Successful bone marrow transplantation with a matched unrelated donor in an acute promyelocytic leukemia patient after reinduction therapy with arsenic trioxide]Toyotaka Iguchi, Kenji Yokoyama, Keisuke Miyamoto, et al.Therapeutic Innovation & Regulatory Science|April 19, 2022
Assessing the Risk of Decrease in Kidney Function in Patients Prescribed Direct-Acting Antivirals for Hepatitis C Utilizing the MID-NET<sup>®</sup> Medical Information Database Network in JapanTomoaki Hasegawa, Sono Sawada, Chieko Ishiguro, et al.Clinical and Translational Science|November 1, 2022
Cardiovascular risk of urate-lowering drugs: A study using the National Database of Health Insurance Claims and Specific Health Checkups of JapanSono Sawada, Kazuhiro Kajiyama, Haruka Shida, et al.Clinical Pharmacology and Therapeutics|January 17, 2023
Characterizing Granulocytopenia Associated with Thiamazole in Patients with Hyperthyroidism Based on Real-World Data from the MID-NET in JapanYuki Kinoshita, Kazuhiro Kajiyama, Chieko Ishiguro, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 1, 2022
[Idiopathic esophageal submucosal hematoma during antithrombotic therapy for essential thrombocythemia]Yosuke Kishi, Yasuo Aota, Yoshimasa Horie, et al.The Journal of Dermatological Treatment|July 4, 2024
Risk of neutropenia in psoriasis patients prescribed anti-IL-23 antibody in comparison with anti-IL-17 antibody or adalimumab based on real-world data from the MID-NET<sup>®</sup> in JapanYusuke Okada, Kazuhiro Kajiyama, Chieko Ishiguro, et al.Frontiers in Medicine|March 13, 2023
Use of National Database of Health Insurance Claims and Specific Health Checkups for examining practical utilization and safety signal of a drug to support regulatory assessment on postmarketing drug safety in JapanHaruka Shida, Kazuhiro Kajiyama, Sono Sawada, et al.Pageof 3